Michael J Droller, MD Email Michael Droller
- PROFESSOR | Urology
- PROFESSOR | Oncological Sciences
- Hospital Affiliation
- The Mount Sinai Hospital
- Urology Associates 212-241-4812 212-241-4812
Michael J. Droller, M.D., is a board certified urologist who received his medical degree cum laude from Harvard Medical School. He completed his internship in internal medicine at the Albert Einstein College of Medicine, went on to begin a surgical residency at the Peter Bent Brigham Hospital in Boston, and then took a position in the US Public Health Service at the National Institutes of Health as a Clinical Associate in the National Institute of Arthritis and Metabolic Diseases to pursue clinical and laboratory investigations. He completed his urology residency at Stanford University Medical Center, spent a year in immunologic research in the Department of Immunology at the University of Stockholm, and then joined the faculty in the Departments of Urology and Oncology at the Johns Hopkins Hospital and School of Medicine. Dr. Droller came to Mount Sinai as Professor and Chairman of the Department of Urology in 1984, serving in that capacity for 19 years and becoming the Katherine and Clifford Goldsmith Professor of Urology (1998) and Professor of Oncology.
Dr. Droller's clinical interests center on urological cancers, with a major focus on bladder cancer and prostate cancer. In pursuing these areas both clincally and in the laboratory, he has also been extensively involved in teaching and communicating to professional colleagues and to the public on these topics, through serving in several major leadership positions for a number of professional organizations and journals. He is currently Editor-in-Chief of Urologic Oncology: Seminars and Original Investigations, which is the official journal of the Society of Urologic Oncology. He has also served as Associate Editor of the Journal of Urology, the official journal of the American Urological Association. He has been Chairman of the Medical Advisory Council for the American Foundation for Urological Diseases, having served as co-Chair for the Bladder Health Council of that organization for 12 years. He has been President and on the Executive Committee of the Society of Urologic Oncology, the Urological Research Society, the New York Section of the American Urological Association, and the New York State Urological Society, and has served as Chairman of the Section of Urology of the New York Academy of Medicine. In addition, he is a member of 15 professional societies and on the editorial board of eight professional journals. His government service has included terms as consultant to the Island Peer Review Organization on the Standards Norms and Criteria Committee and the New York State Department of Health Task Force on Clinical Guidelines and Medical Terminology Assessment.
Dr. Droller Patient Stories:
American Board of Urology
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Congenital Kidney Disease
- Frequent Urination
- Kidney Cancer
- Neurogenic Bladder
- Prostate Cancer
- Prostate Cancer Screening
- Prostate-Specific Antigen (PSA) Test
MD, Harvard Medical School
Internship, Internal Medicine
Albert Einstein College of Medicine
Brigham and Women's Hospital
Stanford University Hospital
English, Spanish, German
American Urological Association
Legends in Urology
Canadian Journal of Urology
Swedish Urologic Association
Career Achievement Award
Societe Internationale d'Urologie
International Bladder Cancer Network
Doctor of Medicine Honoris Causa
University of Athens
German Urological Association
New York Magazine/Castle Connolly
Alpha Omega Alpha, Medical Honor Society
Harvard Medical School
Phi Beta Kappa
Sigma Xi Research Honor Society
Droller MJ. Advanced Bladder Cancer. Philadelphia, Pennsylvania, Urologic Clinics N. America, W.B.Saunders; 1992.
Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. European urology 2016 Jul; 70(1).
Smith JA, Zietman A, Klein E, Droller MJ, Dasgupta P, Catto J, Smith JA. Stage Grouping. The Journal of urology 2016 Jun; 195(6).
Grossman HB, Gomella L, Fradet Y, Droller MJ, Presti J, Ritenovr C, Nseyo U, Morales A. A phase III multicenter comparison of hexaminolevulinate (HAL) flourescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J. Urol. 2007; 178: 622-667.
Droller MJ. Urothelial Tumors. Hamilton Canada, BC Decker, Inc; 2004.
Droller MJ. Bladder Cancer: Current Diagnosis and Treatment. Totowa, New Jersey, Humana Press; 2001.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Droller did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.